Global Parathyroid Hormone Market Report 2021 - Opportunities And Strategies, Market Forecast And Trends

2 Dec, 2021

Check out TBRC’s sale today for

The parathyroid hormone market consists of sales of parathyroid hormones and related services by entities (organizations, sole traders and partnerships) that develop parathyroid hormones to treat various diseases. Parathyroid hormone is responsible for regulating the distribution of phosphate and calcium in the body, and is used in the treatment of diseases such as hypothyroidism and osteoporosis.

Global Parathyroid Hormone Market Size And Drivers:

The global parathyroid hormone market is expected to grow from $1.72 billion in 2020 to $1.79 billion in 2021 at a compound annual growth rate (CAGR) of 4.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The parathyroid hormone market is expected to reach $2.02 billion in 2025 at a CAGR of 3%. The rise in the prevalence of osteoporosis is expected to drive the market for parathyroid hormones.

Request For A Sample For The Global Parathyroid Hormone Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3427&type=smp

Trends In The Global Parathyroid Hormone Market

Companies in parathyroid hormones market are focusing on developing a biosimilar of parathyroid based drugs. A biosimilar is a biological product that is developed to be similar to an already FDA-approved biologic, known as the reference product. Biosimilars potentially offer consumers the opportunity to reduce their health care costs without compromising on treatment standards, thus parathyroid hormones manufacturing companies are investing in it. For instance, in August 2019, Gedeon Richter announced the launch of biosimilar teriparatide caledTerrosa® in Europe. In August 2020, Cadila Pharmaceuticals has launched a teriparatide biosimilar (NuPTH) meant for osteoporosis.

Global Parathyroid Hormone Market Segments:
The global parathyroid hormone market is further segmented –
By Disease Type: Hypocalcemia, Hypoparathyroidism
By End-User: Hospitals, Clinics, Other
By Product Type: Recombinant Parathyroid Hormone, Parathyroid Hormone Analogues
By Geography: The global parathyroid hormone market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Parathyroid Hormone Market At:

https://www.thebusinessresearchcompany.com/report/parathyroid-hormone-global-market-report-2020-30-covid-19-growth-and-change

Parathyroid Hormone Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides parathyroid hormone market overviews, analyzes and forecasts market size and growth for the global parathyroid hormone market, parathyroid hormone market share, parathyroid hormone market players, parathyroid hormone market segments and geographies, parathyroid hormone market’s leading competitors’ revenues, profiles and market shares. The parathyroid hormone market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)